Cs2LiYCl6 (CLYC) is a dual-mode scintillator for simultaneous gamma-ray and neutron detection with excellent Pulse Shape Discrimination between gamma-rays and neutrons, as well as fast neutron spectroscopy.

Dr. Matthew Dallimore Appointed President of Radiation Monitoring Devices, Inc.
Concord, Massachusetts – July 1, 2022 – Dynasil Corporation of America (“Dynasil”) is pleased to announce the appointment of Dr. Matthew Dallimore as President of Radiation Monitoring Devices, Inc. (“RMD”).
“Dr. Dallimore brings a wealth of knowledge and expertise in the fields of science where RMD is a recognized world leader,” said Peter Sulick, President and CEO of Dynasil. “We believe his expertise will be instrumental in continuing to successfully move RMD forward.”
Dr. Dallimore will assume his new role from Dr. Michael Squillante on or before August 1, 2022. Dr. Squillante took over the position of President in March of 2022 upon the passing of Dr. Kanai Shah. Dr. Squillante will assist Dr. Dallimore during a two month transition process prior to his retirement.
“Dr. Dallimore comes to RMD after a long tenure at Symetrica where he was a founding member,” said Dr. Michael Squillante, President of RMD. Following the attainment of his doctoral degree from the University of Southampton, he served Symetrica for two decades in various roles including Lead Scientist, Program Manager, General Manager, Director, and Chief Technology Officer.”
Radiation Monitoring Devices, Inc. (RMD), is recognized worldwide as a foremost expert in the fields of radiation detection, high-speed imaging, nuclear instrumentation, and non-destructive test equipment. Since 1974 RMD’s mission has been to conduct world-class research and develop industry-leading commercial products. Today, that mission is undertaken by more than 60 scientists and engineers who are more often shaping materials research and development rather than following it. Its research and products are utilized in a wide range of scientific fields, from space exploration to particle physics, and from nuclear security and safeguards to clinical diagnoses and environmental research. It holds a vast portfolio of intellectual property, including over 72 granted U.S. patents.
U.S. government agencies, including the DHS, DoE, DTRA, DoD, NIH, and NASA support RMD’s work in developing specialized radiation detection technologies to make the world a safer and healthier place. RMD has been the recipient of two Tibbett’s Award in recognition of its outstanding contributions to the SBIR program. It is also a recipient of the Small Business Achievement Award from the DHS. RMD has successfully commercialized its research into many new technologies. RMD is passionate about working on the most cutting-edge technologies in radiation detection and high-speed imaging and invites inquiries from collaborators, research partners, and customers.